SCHEMBL7142931

SCHEMBL7142931

CCOC(=O)c1cccc(-c2ccc(OC)c3nc(NC(=O)c4ccc(C)s4)nn23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 9/20 0.51
MAPT P10636 4/20 0.42
TP53 P04637 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
CASP3 P42574 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
BRAF P15056 2/20 0.41
DYRK3 O43781 1/20 0.40
CCNT1 O60563 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7762663 0.90 PDE4D (0.57) PDE4DMAPTSMN1; SMN2ALDH1A1NPC1
SCHEMBL7044503 0.88 HPGD (0.43) PDE4DMAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL7766251 0.87 SMN1; SMN2 (0.47) PDE4DMAPTTP53SMN1; SMN2HPGD
SCHEMBL7762520 0.86 JAK2 (0.48) PDE4DMAPTSMN1; SMN2KDM4EHPGD
SCHEMBL6871450 0.85 SMN1; SMN2 (0.45) PDE4DMAPTTP53SMN1; SMN2KDM4E
SCHEMBL7762456 0.85 SMN1; SMN2 (0.45) PDE4DMAPTSMN1; SMN2KMT2ADYRK3
SCHEMBL7146644 0.85 SMN1; SMN2 (0.53) PDE4DMAPTTP53SMN1; SMN2KDM4E
SCHEMBL7143130 0.85 PDE4D (0.52) PDE4DMAPTKDM4ELMNABRAF
SCHEMBL7765386 0.85 JAK2 (0.45) PDE4DMAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL7766283 0.84 FYN (0.47) PDE4DSMN1; SMN2KDM4EDYRK3CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed